Akela reports net income of $1.

Excluding onetime losses and gains, Akela’s consolidated net income for the three and a year ended December 31, 2010 were $0.8 million, and $0.5 million, pitched against a net lack of $2.2 million, and a net lack of $8.4 million.. Akela reports net income of $1.december 31 5 million for three months ended, 2010 Akela Pharma, Inc. , a innovator in the development of therapeutics for the treating pain, and the company’s wholly possessed subsidiary, PharmaForm, announced its financial outcomes for the three months and year ended December 31 today, 2010.The U.S. Attorney’s Office for the Northern District of California filed the complaint requesting the seizure, and coordinated with the FDA. Jan Marini Skin Study provides notified FDA that the company ceased manufacturing and shipping any Age group Intervention Eyelash item containing bimatoprost last year. The FDA recommends that customers, dermatologists, and estheticians who may still have Age Intervention Eyelash discontinue using it and discard any remaining product.